Proposal of the Board of Directors for the appropriation of the available profit
|
in CHF |
|
2024 |
|
2023 |
|
Profit / (loss) for the year |
|
19’032’695 |
|
33’551’684 |
|
Unallocated profit carried forward from previous year |
|
16’024’909 |
|
2’861’343 |
|
Total available profit |
|
35’057’604 |
|
36’413’027 |
|
Ordinary dividend |
|
–20’395’376 |
|
–20’388’118 |
|
Balance carried forward |
|
14’662’228 |
|
16’024’909 |
|
|
|
|
|
|
|
Dividend distribution per share |
|
|
|
|
|
Gross dividend |
|
0.50 |
|
0.50 |
|
Withholding tax (35%) |
|
–0.18 |
|
–0.18 |
|
Net dividend |
|
0.32 |
|
0.32 |
The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 23, 2025. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.